首页> 外国专利> Pyrazole - pyrimidines, Pharmaceutical composition, process and use in myelodysplastic syndrome, myeloproliferative disorders, and cancer

Pyrazole - pyrimidines, Pharmaceutical composition, process and use in myelodysplastic syndrome, myeloproliferative disorders, and cancer

机译:吡唑-嘧啶类药物,在骨髓增生异常综合症,骨髓增生性疾病和癌症中的药物组成,过程和用途

摘要

1: A responsive compound (1) or an acceptable salt for pharmaceutical use, wherein: cycloa is selected from six members of phenyl and isopropyl acyl, in which five or six members of phenyl and isopropyl acyl are replaced by one or more r5s; and X is from - NH -.- that is...Y-S-R1 se selecciona entre H -CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo de 3 a 5 miembros heterociclilo de 5 miembros -OR1a - SR1a -N (R1a) 2 -N (R1a) C (O) R1b N And C (R1a) = n (or1a),In this case, C1-6, c2-6, c2-6, c2-6 tar, carbon thyroid of 3-5 members and isomerized oil of 5 members are replaced by one or more R10; R1a is selected from h, C1-6 tar, carbon thyroid of 3-5 members and isomerized oil of 5 members, among which C1-6 tar, One or more R10 can be selected to replace 3 to 5 members' carbohydrates and 5 members' non bicycles; in each case, r1b is selected from C1-6, alquenilo c2-6, c2-6 tar, 3 to 5 members' carbohydrates and 5 members' non bicycles, Among them, No. C1-6 asphalt,C2-6 alquenilo c2-6, c12-6 asphalt, 3-5 members' carbon thyroid, and 5 members' isomers can be replaced by one or more R10 respectively; R2 can be selected separately between halo-cn, C1-6 asphalt, c2-6 alquenilo c2-6, c2-6 asphalt, carbocyclo, isopropyl-or2a and sr2a. (2) 2) 2A (r22a (R2A (or (R2A) 2) s (o) 2r2b, - C (R2A) = n (R2A),y -C (R2a) 3DN (OR2a)wherein said C1-6alkyl, C2-6alkenyl, C2-6alkynyl, carbocyclyl, and heterocyclyl are optionally substituted with one or more R20; R2a in each occurrence is independently selected from H, C1-6alkyl, carbocyclyl, and heterocyclyl, wherein said C1-6alkyl, carbocyclyl, and heterocyclyl are independently and optionally substituted with one or more R20; R2b in each case is independently selected from C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbocyclyl, and heterocyclyl, wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbocyclyl,y heterociclilo en cada caso y en forma independiente est n opcionalmente sustituidos con uno oms R20 R3 se selecciona entre H halo -CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo heterociclilo -OR3a -SR3a -N (R3a) 2 - y -C (R3a) 3DN (OR3a)wherein said C1-6alkyl, C2-6alkenyl, C2-6alkynyl, carbocyclyl, and heterocyclyl are optionally substituted with one or more R30; R3a in each occurrence is independently selected from H, C1-6alkyl, carbocyclyl, and heterocyclyl, wherein said C1-6alkyl, carbocyclyl, and heterocyclyl are independently and optionally substituted with one or more R30; R3b in each case is independently selected from C1-6alkyl, C2-6alkenyl, C2-6alkynyl, carbocyclyl, and heterocyclyl, wherein said C1-6alkyl, C2-6alkenyl, C2-6alkynyl ,,carbociclilo y heterociclilo en cada caso y en forma independiente est n opcionalmente sustituidos con uno oms R30 R4 se selecciona entre -CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo heterociclilo -N (R4a) C (O) R4b N ( y -C (R4a) 3DN (OR4a)wherein said C1-6alkyl, C2-6alkenyl, C2-6alkynyl, carbocyclyl, and heterocyclyl are optionally substituted with one or more R40; R4a in each occurrence is independently selected from H, C1-6alkyl, carbocyclyl, and heterocyclyl, wherein said C1-6alkyl, carbocyclyl, and heterocyclyl are independently and optionally substituted with one or more R40; R4b in each case is independently selected from C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbocyclyl, and heterocyclyl, wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbocyclyl,y heterociclilo en cada caso y en forma independiente est n opcionalmente sustituidos con uno oms R40 R5 en cada caso se selecciona en forma independiente entre halo -CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo heterociclilo -OR5a -SR5a -N y -C (R5a) 3DN (OR5a)wherein said C1-6alkyl, C2-6alkenyl, C2-6alkynyl, carbocyclyl, and heterocyclyl in each occurrence are optionally substituted with one or more R50; R5a in each occurrence is independently selected from H, C1-6alkyl, carbocyclyl, and heterocyclyl, wherein said C1-6alkyl, carbocyclyl, and heterocyclyl are independently and optionally substituted with one or more R50; R5b in each case is independently selected from C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbocyclyl, and heterocyclyl, wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbocyclyl,y heterociclilo en cada caso y en forma independiente est n opcionalmente sustituidos con uno oms R50 R10 en cada caso se selecciona en forma independiente entre halo -CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo heterociclilo -OR10a -SR10a -N y -C (R10a) 3DN (OR10a)wherein said C1-6alkyl, C2-6alkenyl, C2-6alkynyl, carbocyclyl, and heterocyclyl are independently and optionally substituted with one or more Ra; R10a in each occurrence is independently selected from H, C1-6alkyl, carbocyclyl, and heterocyclyl, wherein said C1-6alkyl, carbocyclyl, and heterocyclyl are independently and optionally substituted with one or more Ra; R10b in each case is independently selected from C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbocyclyl, and heterocyclyl, wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbocyclyl,y heterociclilo en cada caso y en forma independiente est n opcionalmente sustituidos con uno oms Ra R20 en cada caso se selecciona en forma independiente entre halo -CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo heterociclilo -OR20a -SR20a -N y -C (R20a) 3DN (OR20a)wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbocyclyl, and heterocyclyl are independently and optionally substituted with one or more Rb; R20a in each occurrence is independently selected from H, C1-6alkyl, carbocyclyl, and heterocyclyl, wherein said C1-6alkyl, carbocyclyl, and heterocyclyl are independently and optionally substituted with one or more Rb; R20b in each case is independently selected from C1-6alkyl, C2-6alkenyl, C2-6alkynyl, carbocyclyl, and heterocyclyl, wherein said C1-6alkyl, C2-6alkenyl, C2-6alkynyl, carbocyclyl,y heterociclilo en cada caso y en forma independiente est n opcionalmente sustituidos con uno oms Rb R30 en cada caso se selecciona en forma independiente entre halo -CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo heterociclilo -OR30a -SR30a -N And C (r30a) = n (r30a),wherein said C1-6alkyl, C2-6alkenyl, C2-6alkynyl, carbocyclyl, and heterocyclyl are independently and optionally substituted with one or more Rc; R30a in each occurrence is independently selected from H, C1-6alkyl, carbocyclyl, and heterocyclyl, wherein said C1-6alkyl, carbocyclyl, and heterocyclyl are independently and optionally substituted with one or more Rc; R30b in each case is independently selected from C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbocyclyl, and heterocyclyl, wherein said C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, carbocyclyl,y heterociclilo en cada caso y en forma independiente est n opcionalmente sustituidos con uno oms Rc R40 en cada caso se selecciona en forma independiente entre halo -CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo heterociclilo -OR40a SR40a -N ( y -C (R40a) 3DN (OR40a)There they said
机译:1:一种反应性化合物(1)或药学上可接受的盐,其中:环杂选自苯基和异丙基酰基的六元,其中五个或六个苯基和异丙基酰基被一个或多个r 5取代; X来自-NH -.-即... YS-R1硒-H -CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo de 3 a 5 miembros heterociclilo de 5 miembros -OR1a-SR1a- N(R1a)2 -N(R1a)C(O)R1b N和C(R1a)= n(or1a),在这种情况下,C1-6,c2-6,c2-6,c2-6焦油,甲状腺碳3-5个成员中的5个成员和5个成员中的异构化油被一个或多个R10取代; R 1a选自h,C 1-6焦油,3-5个碳原子的甲状腺碳和5个成员的异构油,其中C 1-6焦油,一个或多个R 10可以替代3至5个成员的碳水化合物和5个成员非自行车;在每种情况下,r1b选自C1-6,alquenilo c2-6,c2-6焦油,3至5个成员的碳水化合物和5个成员的非自行车,其中C1-6号沥青,C2-6 Alquenilo c2 -6,c12-6沥青,3-5个成员的甲状腺碳素和5个成员的异构体可以分别被一个或多个R10取代; R 2可以在卤素-cn,C1-6沥青,c2-6烷烃c2-6,c2-6沥青,碳环,异丙基-or2a和sr2a之间分别选择。 (2)2)2A(r22a(R2A(或(R2A)2)s(o)2r2b,-C(R2A)= n(R2A),y -C(R2a)3DN(OR2a),其中上述C1-6烷基, C 2-6烯基,C 2-6炔基,碳环基和杂环基任选地被一个或多个R 20取代; R 2a在每种情况下独立地选自H,C 1-6烷基,碳环基和杂环基,其中所述C 1-6烷基,碳环基和杂环基R 2b独立地并且任选地被一个或多个R 20取代; R 2b在每种情况下独立地选自C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基和杂环基,其中所述C 1-6烷基,C 2-6烯基,C2-6炔基,碳环基,异硫氰酸酯和壳聚糖之间的独立性R20 R3自硒代H卤素-CN alquilo C1-6 Alquenilo C2-6 Alquinilo C2-6-carbocicliloci2 SR 3a -N(R 3a)2 -y -C(R 3a)3DN(OR 3a)其中,所述C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基和杂环基任选地被一个或多个R 30取代;在每种情况下,R 3a各自独立地选自H,C 1-6烷基,碳环基和杂环基,其中所述C 1-6烷基,碳环基和杂环基独立且任选地被一个或多个R 30取代;在每种情况下,R 3b独立地选自C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基和杂环基,其中所述C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基和氮杂基独立推荐的连续性R30 R4硒选择-CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo heterociclilo -N(R4a)C(O)R4b N(y -C(R4a)3DN(OR4a)其中所述C1-6烷基,C2-6链烯基,C2-6炔基,碳环基和杂环基任选地被一个或多个R40取代; R4a在每种情况下独立地选自H,C1-6烷基,碳环基和杂环基,其中所述C1- 6烷基,碳环基和杂环基独立且任选地被一个或多个R 40取代; R 4b在每种情况下独立地选自C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基和杂环基,其中所述C 1-6烷基,C2-6链烯基,C2-6炔基,碳环基,异氰酸酯待定的连续修饰品R40 R5可以独立于卤素-CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo heterociclilo -OR5a -SR5a -N y -C(R OR5a)其中每次出现的所述C1-6烷基,C2-6链烯基,C2-6炔基,碳环基和杂环基任选地被一个或多个R50取代;在每种情况下,R 5a各自独立地选自H,C 1-6烷基,碳环基和杂环基,其中所述C 1-6烷基,碳环基和杂环基独立且任选地被一个或多个R 50取代;在每种情况下,R 5b独立地选自C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基和杂环基,其中所述C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基,y杂环基独立的Cada caso y坐标和R 50 R10的独立参比坐标-CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo异咖啡因-OR10a -SR10 (R10a)3DN(OR10a)其中,所述C1-6烷基,C2-6链烯基,C2-6炔基,碳环基和杂环基独立地并且任选地被一个或多个Ra取代;每次出现时,R 10a独立地选自H,C 1-6烷基,碳环基和杂环基,其中所述C 1-6烷基,碳环基和杂环基独立且任选地被一个或多个Ra取代;在每种情况下,R 10b独立地选自C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基和杂环基,其中所述C 1-6烷基,C 2-6链烯基,C 2-6炔基,碳环基,异硫氰酸盐在形式上独立于表面活性剂,且在R 20上具有独立的选择性独立的卤素-CN Alquilo C1-6 Alquenilo C2-6 Alquinilo C2-6 carbociclilo heterociclilo -OR20a -SR20a -N y -C(R20a)3DN(OR20a)其中C1-6烷基,C2-6链烯基,C2-6炔基,碳环基和杂环基独立且任选地被一个或多个Rb取代;每次出现时,R 20a独立地选自H,C 1-6烷基,碳环基和杂环基,其中所述C 1-6烷基,碳环基和杂环基独立且任选地被一个或多个R b取代; R 20b在每种情况下均独立地选自C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基和杂环基,其中所述C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基,杂环基独立连续性的最佳选择Rb R30 en caada caso se selecciona en forma inentiente halo -CN alquilo C1-6 alquenilo C2-6 alquinilo C2-6 carbociclilo heterociclilo -OR30a -SR30a -N And C(r30a)= n ),其中所述C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基和杂环基独立地并且任选地被一个或多个R c取代;每次出现时,R 30a独立地选自H,C 1-6烷基,碳环基和杂环基,其中所述C 1-6烷基,碳环基和杂环基独立且任选地被一个或多个R c取代;在每种情况下,R 30b独立地选自C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基和杂环基,其中所述C 1-6烷基,C 2-6烯基,C 2-6炔基,碳环基,y杂环基独立于加拿大联邦法院的RCS R40合同,加拿大联邦独立法院(CCN)西班牙加州C1-6 Alquenilo C2-6 Alquinilo C2-6意大利甘草异硫菌-OR40a SR40 (R40a)3DN(OR40a)他们说

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号